Clinical Trial Update: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain [Phase 3]

View source ↗

Summary

A Phase 3 study is evaluating NNC0487-0111 for weight loss and knee osteoarthritis–related pain; the trial status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis
• Obesity

Drugs mentioned

• NNC0487-0111

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Obesity, Knee Osteoarthritis (OA) | Phase 3 | Status: NOT_YET_RECRUITING